SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-11-003216
Filing Date
2011-11-29
Accepted
2011-11-29 15:23:44
Documents
9
Period of Report
2011-08-31

Document Format Files

Seq Description Document Type Size
1 10-K zk1110699.htm 10-K 1608434
2 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3710
3 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 4310
4 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 9410
5 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 9477
6 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5571
7 pwc.jpg GRAPHIC 3423
8 malone.jpg GRAPHIC 6670
9 nexia.jpg GRAPHIC 22100
  Complete submission text file 0001178913-11-003216.txt   1686788
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-50298 | Film No.: 111231035
SIC: 2834 Pharmaceutical Preparations